Trials / Sponsors / Synermore Biologics Co., Ltd.
Synermore Biologics Co., Ltd.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN00 Epithelial Carcinoma, Solid Tumor | Phase 1 | 2020-04-09 |
| Completed | Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies Rabies | Phase 2 | 2019-09-03 |
| Completed | Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects Arthritis, Rheumatoid | Phase 1 | 2017-09-26 |
| Completed | A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines Human Rabies | Phase 1 / Phase 2 | 2016-08-01 |
| Completed | Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors Colon Cancer, Breast Cancer, Cancer of the Head and Neck | Phase 1 | 2015-05-01 |